Pages that link to "Q28196824"
Jump to navigation
Jump to search
The following pages link to Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction (Q28196824):
Displaying 50 items.
- 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (Q22241919) (← links)
- Antiplatelet agents for chronic kidney disease (Q24197614) (← links)
- Antiplatelet agents for chronic kidney disease (Q24200752) (← links)
- Antiplatelet agents for chronic kidney disease (Q24234115) (← links)
- Pharmacologic management of chronic reno-cardiac syndrome (Q26829812) (← links)
- (Q28173786) (redirect page) (← links)
- Treatment and one-year outcome of patients with renal dysfunction across the broad spectrum of acute coronary syndromes (Q28195129) (← links)
- Cardioprotective medication use in hemodialysis patients (Q28199374) (← links)
- Underuse of American College of Cardiology/American Heart Association Guidelines in hemodialysis patients (Q28218895) (← links)
- The implementation of guidelines and prognosis among patients with acute coronary syndromes is influenced by physicians' perception of antecedent physical and cognitive status (Q28219190) (← links)
- Baseline Characteristics and Prescription Patterns of Standard Drugs in Patients with Angiographically Determined Coronary Artery Disease and Renal Failure (CAD-REF Registry) (Q28550033) (← links)
- Management of coronary artery disease and acute coronary syndrome in the chronic kidney disease population-A review of the current literature (Q30238977) (← links)
- Increased mortality among survivors of myocardial infarction with kidney dysfunction: the contribution of gaps in the use of guideline-based therapies (Q33479788) (← links)
- Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Cor (Q33523243) (← links)
- Heart and kidneys (Q33593232) (← links)
- Effect of beta-blockers on the risk of atrial fibrillation in patients with acute myocardial infarction. (Q33754067) (← links)
- A meta-analysis of mortality in end-stage renal disease patients receiving implantable cardioverter defibrillators (ICDs). (Q33921094) (← links)
- Temporal trends in mortality after coronary artery revascularization in patients with end-stage renal disease (Q33975669) (← links)
- Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis (Q34004393) (← links)
- Potential role of differential medication use in explaining excess risk of cardiovascular events and death associated with chronic kidney disease: a cohort study (Q34019491) (← links)
- Management and Outcomes of Renal Disease and Acute Myocardial Infarction (Q34095446) (← links)
- The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease (Q34175429) (← links)
- Antihypertensive medication exposure and cardiovascular outcomes in hemodialysis patients (Q34244180) (← links)
- Suboptimal medical care of patients with ST-elevation myocardial infarction and renal insufficiency: results from the Korea Acute Myocardial Infarction Registry (Q34411141) (← links)
- Heart-Kidney Interaction: Epidemiology of Cardiorenal Syndromes (Q34479128) (← links)
- Antihypertensive agents in hemodialysis patients: a current perspective (Q34700870) (← links)
- Decreased Glomerular Filtration Rate is an Independent Predictor of In-Hospital Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (Q34993743) (← links)
- Geographic variation in cardioprotective antihypertensive medication usage in dialysis patients (Q35120709) (← links)
- Relationship of chronic kidney disease to cardiovascular death and myocardial infarction following coronary stenting. (Q35436297) (← links)
- The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients (Q35436316) (← links)
- Clinical Features of Cardio-Renal Syndrome in a Cohort of Consecutive Patients Admitted to an Internal Medicine Ward (Q35622822) (← links)
- Prevalence and predictors of early cardiovascular events after kidney transplantation: evaluation of pre-transplant cardiovascular work-up (Q35673090) (← links)
- Pharmacological and non pharmacological strategies in the management of coronary artery disease and chronic kidney disease (Q36021782) (← links)
- Cardiovascular risk in chronic renal disease and transplantation prevention and management (Q36161264) (← links)
- A Simple Risk Stratification Model for ST-Elevation Myocardial Infarction (STEMI) from the Combination of Blood Examination Variables: Acute Myocardial Infarction-Kyoto Multi-Center Risk Study Group (Q36190019) (← links)
- Managing cardiovascular risk in people with chronic kidney disease: a review of the evidence from randomized controlled trials (Q36443751) (← links)
- Practical ways to deal with the high burden of cardiovascular disease in hemodialysis patients (Q36448347) (← links)
- Acute coronary syndromes in patients with renal disease: what are the issues? (Q36527848) (← links)
- The association of chronic kidney disease with the use of renin-angiotensin system inhibitors after acute myocardial infarction (Q36557863) (← links)
- Contemporary Management of Coronary Artery Disease and Acute Coronary Syndrome in Patients with Chronic Kidney Disease and End-Stage Renal Disease (Q36721107) (← links)
- Trends in Mortality Following Acute Myocardial Infarction Among Dialysis Patients in the United States Over 15 Years (Q36835957) (← links)
- Associations of kidney function with cardiovascular medication use after myocardial infarction (Q36843434) (← links)
- Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort (Q36877666) (← links)
- Action of irbesartan on blood pressure and glucose/lipid metabolism, in hemodialysis patients with hypertension (Q36906087) (← links)
- Hospital performance and differences by kidney function in the use of recommended therapies after non-ST-elevation acute coronary syndromes (Q37151458) (← links)
- Chronic kidney disease in acute coronary syndromes (Q37195393) (← links)
- Endogenous bradykinin contributes to increased plasminogen activator inhibitor 1 antigen following hemodialysis (Q37367707) (← links)
- Cardiovascular risk and management in chronic kidney disease (Q37454373) (← links)
- Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup (Q37463969) (← links)
- Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease (Q37517937) (← links)